24.38
price up icon0.95%   +0.23
after-market  Handel nachbörslich:  24.38 
loading

Alkermes plc Aktie (ALKS) Neueste Nachrichten

Principal Financial Group Inc. Purchases 864389 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Alkermes plc (NASDAQ:ALKS) Position Decreased by BNP Paribas Financial Markets - MarketBeat

pulisher
MarketBeat

Alkermes plc (NASDAQ:ALKS) Stock Holdings Lowered by BNP Paribas Financial Markets - Defense World

pulisher
Defense World

(ALKS) Pivots Trading Plans and Risk Controls - Stock Traders Daily

pulisher
Stock Traders Daily

Victory Capital Management Inc. Purchases 675 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Charles Schwab Investment Management Inc. Has $59.56 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Natixis Advisors L.P. Has $1.02 Million Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

The Bottom Fishing Club: Alkermes Has Great Value And Safety (NASDAQ:ALKS) - Seeking Alpha

pulisher
Seeking Alpha

Biotech Stock Roundup: ICPT Strong on NASH Drug Data, Collaborations & More - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Russell Investments Group Ltd. Sells 81,673 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

pulisher
MarketBeat

Biogen's (BIIB) Oral MS Drug Vumerity Gets Approval in Europe - Yahoo Singapore News

pulisher
Yahoo Singapore News

Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences - PR Newswire

pulisher
PR Newswire

Swiss National Bank Trims Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Alkermes plc (NASDAQ:ALKS) Shares Sold by Russell Investments Group Ltd. - Defense World

pulisher
Defense World

Teacher Retirement System of Texas Has $12.55 Million Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

pulisher
MarketBeat

Multiple insiders bought Alkermes plc (NASDAQ:ALKS) stock earlier this year, a positive sign for shareholders - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Alkermes (ALKS) Beats on Q2 Earnings & Sales, Ups '21 View - Yahoo Singapore News

pulisher
Yahoo Singapore News

Should You Buy Alkermes (ALKS) Ahead of Earnings? - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

Alkermes plc (NASDAQ:ALKS) Shares Purchased by Los Angeles Capital Management LLC - Defense World

pulisher
Defense World

Sale of Alkermes facility in Athlone is completed - Westmeath Independent

pulisher
Westmeath Independent

117,000 Shares in Alkermes plc (NASDAQ:ALKS) Purchased by LSV Asset Management - MarketBeat

pulisher
MarketBeat

Fisher Asset Management LLC Buys 572 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Cwm LLC Has $55000 Stake in Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

(ALKS) Technical Pivots with Risk Controls - Stock Traders Daily

pulisher
Stock Traders Daily

Alkermes (ALKS) to Report Q4 Earnings: What's in Store? - Yahoo Lifestyle UK

pulisher
Yahoo Lifestyle UK

Alkermes' (NASDAQ:ALKS) Solid Profits Have Weak Fundamentals - Simply Wall St

pulisher
Simply Wall St

Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Alkermes' (ALKS) Schizophrenia, Bipolar I Disorder Drug Approved - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Are Medical Stocks Lagging Alkermes (ALKS) This Year? - Yahoo Singapore News

pulisher
Yahoo Singapore News

BioCryst (BCRX) Wins Japanese Approval for HAE Drug Orladeyo - Yahoo Singapore News

pulisher
Yahoo Singapore News

Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

New York State Common Retirement Fund Buys 11747 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share - Defense World

pulisher
Defense World

Brokers Offer Predictions for Alkermes plc's Q1 2025 Earnings (NASDAQ:ALKS) - MarketBeat

pulisher
MarketBeat

Alkermes plc (NASDAQ:ALKS) Expected to Post Q1 2025 Earnings of $0.43 Per Share - Defense World

pulisher
Defense World

GAMMA Investing LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - Defense World

pulisher
Defense World

Alkermes (NASDAQ:ALKS) Stock Rating Reaffirmed by HC Wainwright - Defense World

pulisher
Defense World

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 49% Undervaluation? - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Alkermes Advances Narcolepsy Drug Studies - Sleep Review

pulisher
Sleep Review

Alkermes Advances Narcolepsy Drug Studies - Sleep Review

pulisher
Sleep Review

Alkermes (ALKS) Grants Teva License to Market Generic Drug - Yahoo Lifestyle UK

pulisher
Yahoo Lifestyle UK

7 Analysts Assess Alkermes: What You Need To Know

pulisher
Benzinga

Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates

pulisher
Zacks Investment Research

Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates - Zacks Investment Research

pulisher
Zacks Investment Research

7 Analysts Assess Alkermes: What You Need To Know - Alkermes (NASDAQ:ALKS) - Benzinga

pulisher
Benzinga

Earnings call: Alkermes reports solid Q1 2024 results, optimistic about pipeline - Investing.com

pulisher
Investing.com

Yousif Capital Management LLC Takes Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

pulisher
MarketBeat

Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say

pulisher
Zacks Investment Research
$65.32
price up icon 0.49%
$17.00
price down icon 1.11%
$55.00
price down icon 0.67%
drug_manufacturers_specialty_generic RDY
$68.71
price up icon 0.66%
$11.07
price up icon 0.82%
$141.65
price down icon 0.45%
Kapitalisierung:     |  Volumen (24h):